BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 15777981)

  • 1. Octreotide treatment for paraneoplastic intestinal pseudo-obstruction complicating SCLC.
    Sørhaug S; Steinshamn SL; Waldum HL
    Lung Cancer; 2005 Apr; 48(1):137-40. PubMed ID: 15777981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paraneoplastic intestinal pseudo-obstruction as the presenting feature of small-cell lung cancer.
    Colombel JF; Parent M; Lescut D; Cortot A; Guillemot F; Plane C; Bonnière P; Lecomte-Houcke M; Paris JC
    Gastroenterol Clin Biol; 1988 Apr; 12(4):394-6. PubMed ID: 2838368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Small bowel pseudo-obstruction revealing an early scleroderma. Long-term efficacy of octreotide and erythromycin].
    Lecomte T; Cavicchi M; Delchier JC
    Gastroenterol Clin Biol; 2000 Mar; 24(3):361-3. PubMed ID: 10804347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraneoplastic intestinal pseudo-obstruction, mononeuritis multiplex, and sensory neuropathy/neuronopathy.
    Simpson DA; Pawlak AM; Tegmeyer L; Doig C; Cox D
    J Am Osteopath Assoc; 1996 Feb; 96(2):125-8. PubMed ID: 8838909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronic intestinal pseudo-obstruction as a paraneoplastic presentation of limited-stage small cell lung cancer].
    Mifune D; Tsukada H; Hosoi M; Okajima M; Yokoyama A
    Nihon Kokyuki Gakkai Zasshi; 2010 Jun; 48(6):439-43. PubMed ID: 20608088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraneoplastic pseudo-obstruction, mononeuropathy multiplex, and sensory neuronopathy.
    Liang BC; Albers JW; Sima AA; Nostrant TT
    Muscle Nerve; 1994 Jan; 17(1):91-6. PubMed ID: 8264708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastric adenocarcinoma presenting with intestinal pseudoobstruction, successfully treated with octreotide.
    Sharma S; Ghoshal UC; Bhat G; Choudhuri G
    Indian J Med Sci; 2006 Nov; 60(11):467-70. PubMed ID: 17090868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal pseudoobstruction as a paraneoplastic syndrome in ganglioneuroblastoma.
    Wildhaber B; Niggli F; Stallmach T; Willi U; Stauffer UG; Sacher P
    Eur J Pediatr Surg; 2002 Dec; 12(6):429-31. PubMed ID: 12548500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term evolution of achalasia of the lower esophageal sphincter and intestinal paraneoplasic pseudo-obstruction revealing small cell lung carcinoma].
    Ceze N; D'Alteroche L; Picon L; Magro P; Monégier du Sorbier C; Metman EH
    Gastroenterol Clin Biol; 2008 Jan; 32(1 Pt. 1):56-8. PubMed ID: 18341977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An enigmatic occlusive syndrome].
    Lescut D; Colombel JF; Parent M; Bonnière P; Guillemot F; Cortot A; Paris JC
    Ann Gastroenterol Hepatol (Paris); 1988; 24(3):115-6. PubMed ID: 3400995
    [No Abstract]   [Full Text] [Related]  

  • 11. Retroperitoneal leiomyosarcoma and gastroparesis: a new association and review of tumor-associated intestinal pseudo-obstruction.
    Lautenbach E; Lichtenstein GR
    Am J Gastroenterol; 1995 Aug; 90(8):1338-41. PubMed ID: 7639243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of painful hypertrophic osteoarthropathy associated with non-small cell lung cancer with octreotide: a case report and review of the literature.
    Birch E; Jenkins D; Noble S
    BMJ Support Palliat Care; 2011 Sep; 1(2):189-92. PubMed ID: 24653233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Octreotide in intestinal pseudo-obstruction?].
    Layer P; Holtmann G
    Z Gastroenterol; 1992 May; 30(5):346-7. PubMed ID: 1632118
    [No Abstract]   [Full Text] [Related]  

  • 14. Severe intestinal pseudoobstruction in a patient with systemic sclerosis. Successful treatment with octreotide.
    Lanting PJ; Kruijsen MW; Rasher JJ; van den Hoogen FH; Boerbooms AM; van de Putte LB
    J Rheumatol; 1993 Dec; 20(12):2175. PubMed ID: 8014959
    [No Abstract]   [Full Text] [Related]  

  • 15. Octreotide in the management of bowel obstruction in terminal ovarian cancer.
    Mangili G; Franchi M; Mariani A; Zanaboni F; Rabaiotti E; Frigerio L; Bolis PF; Ferrari A
    Gynecol Oncol; 1996 Jun; 61(3):345-8. PubMed ID: 8641613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small cell lung cancer in an elderly patient: efficacy of somatostatin analog treatment, a case report.
    Bearz A; Lleshi A; Perin T; Fratino L; Venturini S; Giacalone A; Sartor I; Berretta M; Sulfaro S; Tirelli U
    Onkologie; 2011; 34(3):117-20. PubMed ID: 21358216
    [No Abstract]   [Full Text] [Related]  

  • 17. [Metastatic obstruction of the small bowel revealing or complicating squamous-cell lung cancer. Two cases and a review of the literature].
    Renault PA; Arotçarena R; Calès V; Lippa A; Benichou M; Laurent P; Laborde Y
    Rev Pneumol Clin; 2003 Jun; 59(3):161-5. PubMed ID: 13130203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic intestinal pseudo-obstruction and contaminated small bowel syndrome--treatment with metronidazole, ileostomy, and indomethacin.
    Keshavarzian A; Isaacs P; McColl I; Sladen GE
    Am J Gastroenterol; 1983 Sep; 78(9):562-5. PubMed ID: 6688501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic intestinal pseudoobstruction: report of four pediatric patients.
    Dalgiç B; Sari S; Doğan I; Unal S
    Turk J Gastroenterol; 2005 Jun; 16(2):93-7. PubMed ID: 16252200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paraneoplastic intestinal pseudo-obstruction associated with high titres of Hu autoantibodies.
    Condom E; Vidal A; Rota R; Graus F; Dalmau J; Ferrer I
    Virchows Arch A Pathol Anat Histopathol; 1993; 423(6):507-11. PubMed ID: 8291223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.